In a groundbreaking study published on March 5, 2026, researchers have unveiled an unprecedented link between the gut microbiota and renal cell carcinoma (RCC), one of the most prevalent and lethal forms of kidney cancer. This novel research, led by Lee et al., demonstrates that the probiotic strain Lacticaseibacillus rhamnosus Fb7-311 can modulate the epigenetic regulator EHMT2
Tags: EHMT2 modulation by probioticsEHMT2 role in cancer progressionepigenetic regulation in renal cell carcinomaepigenetic targets in kidney cancergut microbiome influence on epigeneticsgut microbiota and kidney cancergut-kidney axis in cancer therapyLacticaseibacillus rhamnosus Fb7-311 effectsmicrobiota-driven cancer modulationprobiotic strains in oncologyprobiotic treatment for RCCrenal cell carcinoma novel therapies
